Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DaPro: Daptomycin for Sternal Wound Infection Prophylaxis
NCT01080963Phase 4Completed
- Sponsor
- Hannover Medical School
- Start
- Nov 2008
- Primary completion
- Mar 2012
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of daptomycin in sternal wound infection (2 arms), sponsored by Hannover Medical School. Primary endpoint: Incidence of sternal wound infection at 30 days. Started Nov 2008; status: completed.
02
Drugs
daptomycin
03
Conditions
sternal wound infection
Beyond the preview
Go deeper on NCT01080963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080963.